(Q41189041)

28 September 2017

title

The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients (English)

1 reference

28 September 2017

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26498263%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

author name string

Sasitorn Siritho

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26498263%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Kimihiko Kaneko

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26498263%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Kazuo Fujihara

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26498263%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Naraporn Prayoonwiwat

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26498263%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

publication date

23 October 2015

1 reference

Multiple Sclerosis Journal

28 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26498263%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26498263%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26498263%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

page(s)

964-968

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26498263%20AND%20SRC:MED&resulttype=core&format=json

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

5 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458515614093

The spectrum of neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458515614093

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458515614093

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458515614093

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458515614093

Influenza-associated MOG antibody-positive longitudinally extensive transverse myelitis: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458515614093

The spectrum of MOG autoantibody-associated demyelinating diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458515614093

Neuromyelitis optica should be classified as an astrocytopathic disease rather than a demyelinating disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458515614093

MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study: Table 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458515614093